glp 1 agonist mechanism GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes The Impact of GLP-1 Receptor
Description
Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors
Y., et al
How will you monitor me during treatment, and what follow-up is recommended
Another characteristic of study design that might confound comparisons between different agents is the temporal difference in excluding patients in the early post-MI period
26 luglio 2019 [citato 5 giugno 2024];2(4):e00082
Conflict of interest FK and BvS were employees and shareholders of Novo Nordisk A/S
